Ptc Therapeutics (PTCT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2018 | 03-2018 | 12-2017 | 09-2017 | 06-2017 | |
| Sales | 68,743 | 56,062 | 78,030 | 41,853 | 47,962 |
| Cost of Goods | 2,572 | 3,045 | 2,198 | 1,582 | 758 |
| Gross Profit | 66,171 | 53,017 | 75,832 | 40,271 | 47,204 |
| Operating Expenses | 72,317 | 69,805 | 70,578 | 71,745 | 60,459 |
| Operating Income | -5,574 | -16,743 | 5,452 | -30,892 | -12,497 |
| Interest Expense | 2,884 | 3,303 | 3,446 | 3,421 | 3,008 |
| Other Income | -673 | 1,004 | 93 | 766 | -1,820 |
| Pre-tax Income | -9,131 | -19,042 | 2,099 | -33,547 | -17,325 |
| Income Tax | 389 | 221 | 829 | 191 | 150 |
| Net Income Continuous | -9,520 | -19,263 | 1,270 | -33,738 | -17,475 |
| Net Income | $-9,520 | $-19,263 | $1,270 | $-33,738 | $-17,475 |
| EPS Basic Total Ops | -0.21 | -0.46 | 0.09 | -0.82 | -0.44 |
| EPS Basic Continuous Ops | -0.21 | -0.46 | 0.09 | -0.82 | -0.44 |
| EPS Diluted Total Ops | -0.21 | -0.46 | 0.09 | -0.82 | -0.44 |
| EPS Diluted Continuous Ops | -0.21 | -0.46 | 0.09 | -0.82 | -0.44 |
| EBITDA(a) | $643 | $-10,691 | $11,558 | $-20,346 | $-11,399 |